Answer
Daraprim, an antiparasitic drug used to treat toxoplasmosis, experienced a dramatic price increase under the leadership of Martin Shkreli, the former CEO of Turing Pharmaceuticals. In 2015, Shkreli acquired the rights to Daraprim and raised its price from $13.50 per pill to $750 per pill, an increase of over 5,000%.